Compare ARK Genomic Revolution ETF (ARKG) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.61, while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.87. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SJNK | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $44.55 | $25.63 |
52-Week Low | $24.02 | $24.75 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $44.69 with a 0.86% daily gain, showing bullish momentum with strong moving average signals but overbought oscillators. The ETF focuses on genomic revolution companies with 59% concentration in top 10 holdings and long-term EPS growth of 10.7%. Recent news highlights biotech sector strength and ARKG's recovery from July correction.
Outlook remains positive given biotech sector tailwinds including FDA friendliness and AI-driven drug discovery, though high RSI readings suggest near-term caution. Key risks include sector volatility and concentrated portfolio exposure.
SJNK trades at $24.87, up 0.16% on the day, with a bearish technical signal from moving averages and neutral oscillators. The ETF shows consistent dividend distributions, with recent payouts of $0.14-$0.15. Institutional activity includes Cetera Investment Advisers reducing its position by 9.4% as of July 28, 2026, while news sentiment reflects caution on high-yield bonds.
The outlook remains cautious due to technical bearishness and negative media coverage, with risks from interest rate sensitivity and credit spreads. Investment appeal hinges on yield stability, but macroeconomic headwinds could pressure performance. Analysts highlight correlated vulnerabilities with broader junk bond ETFs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
